CNR Institutional Research Information System

LAMPIASI, NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 426
AS - Asia 143
EU - Europa 55
Totale 624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 426
SG - Singapore 135
IT - Italia 40
FI - Finlandia 10
CN - Cina 6
DE - Germania 3
HK - Hong Kong 2
NL - Olanda 2
Totale 624
Salva come PNG Salva come JPEG
Città #
Santa Clara 400
Singapore 101
Palermo 14
Helsinki 10
Forest City 3
Braunschweig 2
Ferrara 2
Hong Kong 2
Lawrenceburg 2
Phoenix 2
Ashburn 1
Baltimore 1
Boardman 1
Canicattì 1
Falkenstein 1
Fort Worth 1
Groningen 1
Guangzhou 1
Pescara 1
Prosper 1
Seattle 1
Totale 549
Salva come PNG Salva come JPEG
Nome #
A new ginger extract characterization: immunomodulatory, antioxidant effects and differential gene expression 31
The sea urchin embryo and the cell stress responses: new perspectives 22
Inflammation and the Potential Implication of Macrophage-Microglia Polarization in Human ASD: An Overview 16
Neurotoxicity in marine invertebrates: An update 13
Mirnas expression profiling in raw264.7 macrophages after nfatc1-knockdown elucidates potential pathways involved in osteoclasts differentiation 11
Osteoclasts differentiation from murine RAW 264.7 cells stimulated by RANKL: Timing and behavior 11
A factor secreted by human embryo stimulates cytokine release by uterine mast cell. 11
The Migration and the Fate of Dental Pulp Stem Cells 10
Long-Lasting Activity of ERK Kinase Depends on NFATc1 Induction and Is Involved in Cell Migration-Fusion in Murine Macrophages RAW264.7 10
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 9
The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells 9
Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. 9
New Strategies for Macrophage Re-Education in Cancer: An Update 9
Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. 9
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells 8
The Alternative Faces of Macrophage Generate Osteoclasts 8
Sperimento...ergo sum: Studenti al banco di laboratorio 8
COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. 8
Probing safety of nano-objects by defining immune responses of environmental organisms 8
In silico insights and molecular characterization between IKK kinase and some ligands 8
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 8
INVOLVEMENT OF p38 AND JNK mapks PATHWAYS IN SUBSTANCE P-INDUCED PRODUCTION OF TNF - BY PERITONEAL MAST CELLS 8
Effect of substance P on uterine mast cell cytokine release during the reproductive cycle. 8
Macrophage Polarization: Learning to Manage It 2.0 7
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway 7
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. 7
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. 7
Gene Expression Profiling of NFATc1-Knockdown in RAW 264.7 Cells: An Alternative Pathway for Macrophage Differentiation 7
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 7
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. 7
Gene expression profiling of human liver cancer cells following celecoxib treatment. 7
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. 7
Inhibitory effect of neuraminidase on SP-induced histamine release and TNF-alpha mRNA in rat mast cells: evidence of a receptor-independent mechanism. 7
The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. 7
Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. 7
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 7
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 7
Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. 7
The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism 7
Development of nimesulide loaded solid lipid nanoparticles. 7
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 7
DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. 7
Mast cell production of TNF-alpha induced by substance P evidence for a modulatory role of substance P-antagonists. 6
Macrophage polarization: learning to manage it 6
The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. 6
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. 6
Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. 6
Interaction between Embryo Histamine Releasing Factor (EHRF) and uterine mast cell. 6
Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells 6
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery 6
DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. 6
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells 6
2015-2017 Accordo di cooperazione scientifica CNR/RFBR (Russian Foundation for Basic Research) : "Cell-cell fusion in vertebrate and invertebrate short-term cultures: ultrastructural, cellular and molecular analyses and role of ECM molecules, growth factors and miRNAs" 6
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. 6
Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. 6
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 6
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells 6
Toxic mineral elements in Mytilus galloprovincialis from Sicilian coasts (Southern Italy) 6
Induction of Apoptosis and Inhibition of Cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 6
Gli organismi viventi come esempio di plasticità e interazione con l'ambiente esterno 6
The molecular events behind ferulic acid mediated modulation of IL-6 expression in LPS-activated RAW 264.7 6
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 6
An in vitro inflammation model to study the Nrf2 and NF-kB crosstalk in presence of ferulic acid as modulator. 6
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. 6
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. 6
Cyclooxygenases in cancer 6
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. 6
Solid-lipid nanoparticles for gene delivery to cells. 6
Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens. 5
Solid lipid nanoparticles (SLNs) containing nimesulide: preparation, characterization and in cytotoxicity studies 5
G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 5
Natural Molecules as IKK a/b Inhibitors useful in the Treatment of Inflammation 5
Substance P induces HO-1 expression in RAW 264.7 cells promoting switch towards M2-like macrophages 5
MITF: an evolutionarily conserved transcription factor in the sea urchin Paracentrotus lividus 5
Molecular mechanisms of sorafenib action in liver cancer cells. 5
Estrogens and EHRF are important factors for the Embryo Implantation Step. 5
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 5
Substance P induces TNF-alpha and IL-6 production through NFkB in peritoneal mast cells 5
Interactions between Macrophages and Mast Cells in the Female Reproductive System 5
Regulation of the Phenotype and Function of Human Macrophages and Dendritic Cells by Exogenous Immunomodulators 5
Oestradiol enhances in vitro the histamine release induced by embryonic histamine-releasing factor (EHRF) from uterine mast cells. 4
Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells 4
Poly (ADP-ribose) polymerase inhibition synergizes with the NF-kB inhibitor DHMEQ to kill hepatocellular carcinoma cells. 4
Dispersal of rat uterine mast cells and their functional response to an embryo-derived histamine releasing factor: a possible model for embryo implantation. 4
Growth suppression and apoptosis induction in human hepatoma cells by DHMEQ, a novel NF-KB inhibitor, is mediated through a ROS-dependent mechanism. 4
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells 4
Antigens of Euparipha pisana (snail). I. Identification of allergens by means of in vivo and in vitro analysis. 4
United we stand: Adhesion and molecular mechanisms driving cell fusion across speciestand 4
Poly (ADP-ribose) polymerase inhibition synergizes with the NF-kB inhibitor DHMEQ to kill hepatocellular carcinoma cells 4
Histamine and tumor necrosis factor-alpha production from purified rat brain mast cells mediated by substance P. 4
Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies. 4
Corrigendum to "Poly (ADP-ribose) polymerase inhibition synergizes with the NF-?B inhibitor DHMEQ to kill hepatocellular carcinoma cells" [Biochim. Biophys. Acta 1843 (2014) 2662-2673] 4
Cationic Solid-lipid nanoparticles as DNA carriers. 4
DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. 4
Cationic solid-lipid nanoparticles for gene delivery. 4
Totale 661
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.534
article - articoli 1.437
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 75
Totale 4.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202455 0 0 0 0 0 0 0 0 34 12 4 5
2024/2025606 17 7 96 42 373 71 0 0 0 0 0 0
Totale 661